Insulet Corp. (PODD)
294.17
-1.02
(-0.35%)
USD |
NASDAQ |
Dec 11, 16:00
294.62
+0.45
(+0.15%)
After-Hours: 20:00
Insulet Research and Development Expense (Quarterly): 77.20M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| ResMed, Inc. | 87.32M |
| Baxter International, Inc. | 115.00M |
| Tandem Diabetes Care, Inc. | 47.88M |
| Masimo Corp. | 30.50M |